A Silver Lining? Fewer Non–Severe Acute Respiratory Syndrome Coronavirus 2 Respiratory Viruses During the Coronavirus Disease 2019 Pandemic | Zendy

Zachary Most | Zendy; Michael J. Holcomb | Zendy; Andrew R. Jamieson | Zendy; Trish M. Perl | Zendy

Open Access

A Silver Lining? Fewer Non–Severe Acute Respiratory Syndrome Coronavirus 2 Respiratory Viruses During the Coronavirus Disease 2019 Pandemic

Author(s) -

Zachary Most,

Michael J. Holcomb,

Andrew R. Jamieson,

Trish M. Perl

Publication year - 2021

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jiab191

Subject(s) - pandemic , covid-19 , coronavirus , respiratory system , virology , medicine , betacoronavirus , disease , infectious disease (medical specialty) , outbreak

Nonpharmaceutical interventions (NPIs) have “flattened the curve” of the coronavirus disease 2019 pandemic; however the effect of these interventions on other respiratory viruses is unknown. We used aggregate level case count data for 8 respiratory viruses and compared the institutional and statewide case counts before and during the period that NPIs were active. We observed a 61% decrease (incidence rate ratio, 0.39; 95% confidence interval, .37–.41; P < .001) in non–severe acute respiratory syndrome coronavirus 2 respiratory viral infections when NPIs were implemented. This finding, if further verified, should guide future public health initiatives to mitigate viral epidemics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research